| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.22B | 10.82B | 10.52B | 7.44B | 7.15B | 8.95B |
| Gross Profit | 6.60B | 6.46B | 6.22B | 4.51B | 3.77B | 4.62B |
| EBITDA | 1.18B | 1.06B | 4.68B | 3.21B | 2.42B | 3.34B |
| Net Income | 710.13M | 710.48M | 743.38M | 277.69M | 785.45M | 1.67B |
Balance Sheet | ||||||
| Total Assets | 74.38B | 76.01B | 64.36B | 57.91B | 51.06B | 56.11B |
| Cash, Cash Equivalents and Short-Term Investments | 11.96B | 14.04B | 12.15B | 8.53B | 9.70B | 10.76B |
| Total Debt | 32.31B | 23.76B | 20.36B | 16.09B | 13.72B | 11.42B |
| Total Liabilities | 63.72B | 65.37B | 54.13B | 48.10B | 40.76B | 45.38B |
| Stockholders Equity | 10.61B | 10.57B | 10.16B | 9.71B | 10.23B | 10.68B |
Cash Flow | ||||||
| Free Cash Flow | -729.53M | -1.71B | -459.84M | -1.93B | 1.58B | 1.42B |
| Operating Cash Flow | -571.64M | -1.50B | -209.25M | -1.93B | 1.80B | 1.58B |
| Investing Cash Flow | -370.30M | -298.81M | 210.31M | -12.20M | -60.54M | -409.87M |
| Financing Cash Flow | 2.19B | 3.59B | 3.35B | 1.06B | -2.84B | 994.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $5.58B | 20.12 | 22.08% | 1.63% | 12.77% | 36.43% | |
71 Outperform | $4.91B | 22.13 | 44.30% | 3.69% | 51.19% | 456.59% | |
70 Outperform | $12.91B | 25.51 | 33.81% | 0.95% | 27.00% | 63.47% | |
70 Outperform | $11.91B | 12.55 | 11.96% | 1.43% | 7.54% | 2.73% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $10.32B | 24.90 | 20.14% | 1.33% | 20.99% | 25.02% | |
49 Neutral | $8.94B | 13.64 | 9.47% | 2.52% | -5.41% | 25.28% |